Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures
Clinical trial NCT01162460 · COMPLETED
Trial details
- NCT number
- NCT01162460
- Sponsor
- Bial - Portela C S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2016-09-01
- Enrollment
- 815
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.